Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Ilson · SciRah

Researcher profile · Semantic Scholar

D. Ilson

Share profile

D. Ilson — researcher profile on SciRah

h-index: 62
Works: 655
Citations: 17K

Most-cited papers

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J. Ajani, T. D'Amico, D. Bentrem, J. Chao +37 more
2022The Journal of the National Comprehensive Cancer Network1,522 citations Open access
Semantic Scholar
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J. Ajani, T. D'Amico, D. Bentrem, David T. Cooke +38 more
2023The Journal of the National Comprehensive Cancer Network803 citations Open access
Semantic Scholar
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial.
K. Shitara, F. Lordick, Y. Bang, P. Enzinger +16 more
2023The Lancet652 citations
Semantic Scholar
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
J. Ajani, Thomas A. D'Amico, D. Bentrem, Carlos U. Corvera +38 more
2025The Journal of the National Comprehensive Cancer Network226 citations
Semantic Scholar
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial
H. Safran, K. Winter, D. Ilson, D. Wigle +18 more
2022The Lancet Oncology94 citations Open access
Semantic Scholar
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
K. Shitara, M. A. Shah, F. Lordick, E. Van Cutsem +17 more
2024New England Journal of Medicine77 citations Open access
Semantic Scholar
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
S. Klempner, Keun-Wook Lee, K. Shitara, J. Metges +12 more
2023Clinical Cancer Research66 citations Open access
Semantic Scholar
Gastric Cancer, Version 2.2022
J. Ajani, D. ThomasA., Amico, D. Bentrem +38 more
202243 citations
Semantic Scholar
Clinical and Molecular Characteristics of Early-Onset versus Average-Onset Esophagogastric Cancer.
M. Lumish, H. Walch, S. Maron, W. Chatila +21 more
2023Journal of the National Cancer Institute35 citations Open access
Semantic Scholar
First-line regorafenib with nivolumab and chemotherapy in advanced esophageal, gastric, or gastroesophageal junction cancer: an open-label, single-arm phase 2 trial
S. Cytryn, Ryan H. Moy, Darren Cowzer, Ronak H. Shah +26 more
2023The Lancet Oncology33 citations Open access
Semantic Scholar
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
S. Maron, W. Chatila, H. Walch, Joanne F. Chou +30 more
2023Clinical Cancer Research32 citations Open access
Semantic Scholar
Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
M. Strickland, E. Lander, Michael K. Gibson, D. Ilson +2 more
2024The Journal of the National Comprehensive Cancer Network31 citations Open access
Semantic Scholar
Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.
Rui-Hua Xu, K. Shitara, J. Ajani, Y. Bang +16 more
2023Journal of Clinical Oncology29 citations
Semantic Scholar
Outcomes of neoadjuvant chemotherapy in clinical stage II/III gastric cancer patients: analysis of timing and site of recurrence
Masaya Nakauchi, E. Vos, Laura H. Tang, M. Gonen +8 more
2021Annals of Surgical Oncology26 citations Open access
Semantic Scholar
Zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) withclaudin-18.2+ (CLDN18.2+) / HER2− locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary results from phase 3 SPOTLIGHT study
K. Shitara, F. Lordick, Y. Bang, P. Enzinger +15 more
2023Journal of Clinical Oncology24 citations
Semantic Scholar
Survival of locally advanced MSI-high gastric cancer patients treated with perioperative chemotherapy: a retrospective cohort study
E. Vos, S. Maron, R. Krell, Masaya Nakauchi +13 more
2022Annals of Surgery22 citations
Semantic Scholar
Advances in the treatment of gastric cancer: 2020–2021
D. Ilson
2021Current Opinion in Gastroenterology22 citations Open access
Semantic Scholar
Perioperative versus total neoadjuvant chemotherapy in gastric cancer
Jessica Yang, M. Greally, V. Strong, D. Coit +7 more
2023Journal of Gastrointestinal Oncology19 citations Open access
Semantic Scholar
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma
Charlton Tsai, B. Nguyen, A. Luthra, Joanne F. Chou +16 more
2022JAMA Network Open17 citations Open access
Semantic Scholar
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
H. Walch, Raktim Borpatragohain, J. Jee, W. Chatila +19 more
2025Clinical Cancer Research16 citations Open access
Semantic Scholar
Dupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series
I. Nykaza, A. Moy, S. Dusza, A. Moskowitz +9 more
2025The Oncologist15 citations Open access
Semantic Scholar
Final overall survival results from phase 3 SPOTLIGHT study evaluating zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma.
K. Shitara, E. Van Cutsem, F. Lordick, P. Enzinger +14 more
2024Journal of Clinical Oncology15 citations Open access
Semantic Scholar
Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers
B. Diplas, R. Ptashkin, Joanne F. Chou, Shalom Sabwa +23 more
2023JAMA Network Open15 citations Open access
Semantic Scholar
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)
K. Shitara, T. Doi, H. Hosaka, P. Thuss-Patience +12 more
2022Gastric Cancer13 citations Open access
Semantic Scholar
Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer
Nicole M. Myer, K. Shitara, H. Chung, F. Lordick +6 more
2022Journal of Cancer Research and Clinical Oncology12 citations Open access
Semantic Scholar
Advances in the treatment of gastric cancer: 2022–2023
D. Ilson
2023Current Opinion in Gastroenterology10 citations
Semantic Scholar
Waiting to Operate: The Risk of Salvage Esophagectomy
T. Boerner, C. Harrington, K. Tan, P. Adusumilli +14 more
2023Annals of Surgery10 citations
Semantic Scholar
Circulating Tumor and Invasive Cell Expression Profiling Predicts Effective Therapy in Pancreatic Cancer
K. Yu, Jennifer Park, Avni Mittal, G. Abou-Alfa +16 more
2022Cancer9 citations Open access
Semantic Scholar
Durvalumab and PET-directed chemoradiation in locally advanced esophageal adenocarcinoma – A phase Ib/II study
Darren Cowzer, A. Wu, S. Sihag, H. Walch +18 more
2023Annals of Surgery8 citations
Semantic Scholar
The interaction between microsatellite instability high (MSI-high) gastric cancer and chemotherapy on survival.
E. Vos, S. Maron, R. Krell, Masaya Nakauchi +9 more
20218 citations
Semantic Scholar
Supporting Patients with Cancer after Dobbs v. Jackson Women’s Health Organization
A. Shuman, M. Aapro, Benjamin Anderson, K. Arbour +34 more
2022The Oncologist7 citations Open access
Semantic Scholar
SURPASS-2 trial design: A phase 2, open-label study of ADP-A2M4CD8 SPEAR T cells in advanced esophageal or esophagogastric junction cancers.
D. Hong, S. Jalal, E. Elimova, J. Ajani +12 more
2022Journal of Clinical Oncology7 citations
Semantic Scholar
Induction FOLFOX and PET-directed chemoradiation for locally advanced esophageal adenocarcinoma
R. Carr, M. Hsu, C. Harrington, K. Tan +13 more
2021Annals of Surgery7 citations Open access
Semantic Scholar
KEYNOTE-585 FAILS WHILE MATTERHORN SUCCEEDS IN GASTRIC CANCER: WHAT LESSONS CAN WE LEARN?
D. Ilson
2025Journal of Clinical Oncology6 citations
Semantic Scholar
Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases
Samuel D. Butensky, Varun V. Bansal, David G. Su, Muhammad Talha Waheed +239 more
2024Annals of Surgical Oncology6 citations
Semantic Scholar
Immunotherapy in Esophagogastric Cancer
D. Ilson
2021Clinical advances in hematology & oncology : H&O6 citations
Semantic Scholar
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study
W. Mansoor, H. Arkenau, M. Alsina, K. Shitara +14 more
2021Gastric Cancer6 citations Open access
Semantic Scholar
Clinical pharmacology profile of the claudin 18.2 antibody zolbetuximab.
Jianning Yang, Akihiro Yamada, S. Klempner, S. Lonardi +9 more
2024Journal of Clinical Oncology5 citations
Semantic Scholar
A nutritional management algorithm in older patients with locally advanced esophageal cancer
R. H. Moy, Shalom Sabwa, S. Maron, Marina Shcherba +9 more
2021Journal of Geriatric Oncology5 citations
Semantic Scholar
AMIGO: A phase 2 trial of amivantamab in EGFR or MET- amplified gastroesophageal adenocarcinoma (GEA).
S. Maron, Charlton Tsai, M. Strickland, J. Chou +14 more
2026Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: a case series
T. Boerner, R. Carr, M. Hsu, K. Tan +14 more
2023International Journal of Surgery4 citations Open access
Semantic Scholar
How to use anti-PD-1 therapy in gastric cancer: the approach in the United States
D. Ilson
2023Chinese Clinical Oncology4 citations Open access
Semantic Scholar
Emerging evidence for VEGF and immune checkpoint inhibition in oesophagogastric cancer.
D. Ilson
2022The Lancet Gastroenterology and Hepatology4 citations
Semantic Scholar
KEYNOTE-585: disappointing results for perioperative pembrolizumab in gastric cancer
D. Ilson
2023Translational Gastroenterology and Hepatology3 citations
Semantic Scholar
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
R. H. Moy, M. Greally, Joanne F. Chou, Jia Li +8 more
2022Cancer Chemotherapy and Pharmacology3 citations
Semantic Scholar
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.
S. Cytryn, Raktim Borpatragohain, Karmelina Charalambous, William Phu +25 more
2026JCO Precision Oncology2 citations
Semantic Scholar
Genomic and clinical parallels between US and Japanese gastric cancers: a propensity score-matched cohort study.
Masaya Nakauchi, C. Court, H. Walch, Miseker Abate +14 more
2025British Journal of Surgery2 citations
Semantic Scholar
Association of ERBB2 extrachromosomal DNA (ecDNA) with first-line HER2-targeted treatment outcomes in advanced esophagogastric adenocarcinoma (EGC).
Charlton Tsai, Shalabh Suman, Cynthia Chu, J. Chou +8 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma.
G. Ku, A. Wu, Nikhil Trivedi, S. Maron +11 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery
L. Kachnic, Kathryn A. Winter, Mohan Suntharalingam, D. Ilson +16 more
2024Quality of Life Research2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Y. Janjigian×21
Invite
Y. Janjigian — researcher profile on SciRah
S. Maron×19
Invite
S. Maron — researcher profile on SciRah
G. Ku×17
Invite
G. Ku — researcher profile on SciRah
V. Strong×13
Invite
V. Strong — researcher profile on SciRah

×12

Invite

M. Capanu — researcher profile on SciRah

Invite

J. Ajani — researcher profile on SciRah

S. Klempner×10

Invite

S. Klempner — researcher profile on SciRah

Invite

K. Shitara — researcher profile on SciRah

Invite

D. Molena — researcher profile on SciRah

Invite

H. Walch — researcher profile on SciRah

Invite

S. Sihag — researcher profile on SciRah

Invite

P. Enzinger — researcher profile on SciRah